pBabe puro C-Raf 22W Citations (5)

Originally described in: Oncogenic Ras blocks anoikis by activation of a novel effector pathway independent of phosphatidylinositol 3-kinase.
McFall A, Ulku A, Lambert QT, Kusa A, Rogers-Graham K, Der CJ Mol Cell Biol. 2001 Aug . 21(16):5488-99. PubMed Journal

---

Articles Citing pBabe puro C-Raf 22W

Articles
FAM83B mediates EGFR- and RAS-driven oncogenic transformation. Cipriano R, Graham J, Miskimen KL, Bryson BL, Bruntz RC, Scott SA, Brown HA, Stark GR, Jackson MW. J Clin Invest. 2012 Sep;122(9):3197-210. doi: 10.1172/JCI60517. Epub 2012 Aug 13. PubMed
FAM83B-mediated activation of PI3K/AKT and MAPK signaling cooperates to promote epithelial cell transformation and resistance to targeted therapies. Cipriano R, Miskimen KL, Bryson BL, Foy CR, Bartel CA, Jackson MW. Oncotarget. 2013 May;4(5):729-38. PubMed
Rapamycin antagonizes TNF induction of VCAM-1 on endothelial cells by inhibiting mTORC2. Wang C, Qin L, Manes TD, Kirkiles-Smith NC, Tellides G, Pober JS. J Exp Med. 2014 Mar 10;211(3):395-404. doi: 10.1084/jem.20131125. Epub 2014 Feb 10. PubMed
HOP expression is regulated by p53 and RAS and characteristic of a cancer gene signature. Mattison SA, Blatch GL, Edkins AL. Cell Stress Chaperones. 2016 Dec 16. PubMed
Ras oncogene-independent activation of RALB signaling is a targetable mechanism of escape from NRAS(V12) oncogene addiction in acute myeloid leukemia. Pomeroy EJ, Lee LA, Lee RD, Schirm DK, Temiz NA, Ma J, Gruber TA, Diaz-Flores E, Moriarity BS, Downing JR, Shannon KM, Largaespada DA, Eckfeldt CE. Oncogene. 2016 Dec 19. doi: 10.1038/onc.2016.471. PubMed

If you have published an article using this material, please email us at to have your article added to this page.